Poll: What is your first-line approach to emergent presbyopes who wear contact lenses?

Poll

This poll is for optometrists and eyecare professionals, only. It will close on Friday, August 13, 2021.

What is your first-line approach to emergent presbyopes who wear contact lenses?

A. Multifocal contact lenses
B. Monovision contact lenses
C. Low-power readers over single-vision contact lenses
D. Low-power readers over single-vision contact lenses
Recent Videos
Spencer Johnson, OD, FAAO, overviews his talk on laser procedures at Optometry's Meeting
Raman Bhakhri, OD, FAAO, overviews his talk on medications' potential side effects on the retina with Optometry Times
Edmund Tsui, MD, details what insights swept-source anterior segment OCT images may give to determining eye inflammation
Charles Leclercq, CEO of ARxVision, details the new ARx AI headset and its uses
Jacob R. Lang, OD, FAAO
Easy Anyama
Related Content
Scientist studying trial results on several computer screens Image Credit: AdobeStock/Thitiphan/AI

Coupling of clinical trial recruitment and AI eases the burden of GA studies

Lynda Charters
July 17th 2024
Article
Podcast: Look back at contact lenses in 2020

Podcast: Look back at contact lenses in 2020

December 17th 2020
Podcast
Business meeting in office Image credit: ©alfa27 - adobe.stock.com

Alcon announces closing of acquisition of Belkin Vision

Jordana Joy, Associate Editor
July 5th 2024
Article
Defocus Media: Know the building blocks for vision therapy

Defocus Media: Know the building blocks for vision therapy

Jennifer Lyerly, OD
December 17th 2020
Podcast
Graphic of human and robot hands touching Image credit: ©ipopba - adobe.stock.com

All eyes on the future: How AI is revolutionizing ocular surgery

Cecelia Koetting, OD, FAAO, DipABO
June 24th 2024
Article
Boy wearing virtual reality headset Image credit: ©Brian Jackson - adobe.stock.com

Dopavision announces topline results for MyopiaX trial for slowing pedatric myopia progression

Jordana Joy, Associate Editor
May 29th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.